Livemedia Home

Previous Events


Next Events

facebook_icon twitter_icon youtube_icon google_plus_icon instagram rss_icon

 Login / Register to Livemedia



Forgot your password?

A+ | A-
GR | EN

11/03/2017 Congresses | Video | 9th International Congress of Internal Medicine | P.Montravers | Reducing the antifungal drugs consumption in the ICU

 
277 VIEWS EXPANDCOLLAPSE Presentation

Share

75.234 total
8 live
277 video
38.535 photo
Views:

16:00-17:30 ROUND TABLE
Πρόεδροι: G.Dimopoulos
16:00-16:25 Prevention of ventilator-associated pneumonia (VAP): Could be realistic?
S.Blot
16:25-16:50 Reducing the antifungal drugs consumption in the ICU
P.Montravers
16:50-17:15 Fighting multi-drug resistant (MDR) pathogens in the ICU
M.Akova
17:15-17:30 Discussion


 
Sort by Date | Views

Watch On Demand: 9th International Congress of Internal Medicine

Dates: March 9-11, 2017
Venue: Hilton Athens Hotel,Athens, Greece
Organization: Institute of Internal Medicine & Hepatology, Larissa, Greece

Department of Medicine & Research Laboratory of Internal Medicine
University of Thessaly Medical School, Larissa, Greece

Director: Professor G.N. Dalekos

Under the auspices of: University of Thessaly Medical School, Larissa, Greece
Website: www.internalmedicine-uth.gr

For the program, please click here.

P. Mallis | ORAL PRESENTATIONS OP01-OP09 495
E, Sevim | ORAL PRESENTATIONS OP01-OP09 344
R. Sivritepe | ORAL PRESENTATIONS OP01-OP09 350
V. Papavasileiou | ORAL PRESENTATIONS OP01-OP09 316
R. Sivritepe | ORAL PRESENTATIONS OP01-OP09 386
G. Ntaios | ORAL PRESENTATIONS OP01-OP09 303
S. O. Serin | ORAL PRESENTATIONS OP01-OP09 319
G. Ntetskas | ORAL PRESENTATIONS OP01-OP09 289
R.Liberal | Importance of European registries... 330
C.Packard | Should we treat everyone above... 609
K.Hovingh | Familial hypercholesterolemia... 543
T.Pedersen | PCSK9 inhibition: What is hot... 450
M.Burnier | Pros 350
K. P. Makaritsis Cons 403
Discussion - Questions 249
682
J.Putaala | Stroke in the young 349
J.Ferro | Drug-induced stroke 360
D.Strbian | Can we predict thrombolysis-associated... 348
C.Weimar | Management of intracranial artery... 343
Gk. Katsifis | SATELLITE LECTURE Sponsored... 439
H.Mattle | Patent foramen ovale in cryptogenic... 359
G. N. Dalekos | Welcome 312
Vravefsi | OPENING CEREMONY 238
D.Sereni | Inaugural Lecture 281
M Papatheodoridi | ORAL PRESENTATIONS OP10-OP18 409
S. Savvanis | ORAL PRESENTATIONS OP10-OP18 265
V. Ligoyra | ORAL PRESENTATIONS OP10-OP18... 238
K. Azariadi | ORAL PRESENTATIONS OP10-OP18... 253
I. Mani | ORAL PRESENTATIONS OP10-OP18 277
S. Karatapanis | ORAL PRESENTATIONS OP10-OP18 220
P. Arvaniti | ORAL PRESENTATIONS OP10-OP18 288
A. Molyvdas | ORAL PRESENTATIONS OP10-OP18 275
T. Karaoulani | ORAL PRESENTATIONS OP10-OP18 253
H.Toplak | Epidemiology, definition and... 319
P.Nilsson | Obesity, impaired glucose metabolism... 359
V.Kotsis | Mechanisms of obesity induced... 385
J. Jordan | Novel drugs in the treatment... 356
H.Wedemeyer | Chronic hepatitis C: Challenges... 323
Q&A | ROUND TABLE 280
C.Yurdaydin | Chronic hepatitis delta: An... 310
L.Guillevin | Treatment of ANCA-associated... 350
M.Rizzo | Novel approaches to manage dyslipidaemia,... 352
M.Samson | Biological-targeted treatments... 341
P.Valensi | Silent myocardial ischaemia... 259
Y.Renaudineau | Primary Sjögren’s syndrome:... 317
D.Ziegler | Diabetic neuropathy: New developments... 270
Q & A | ROUND TABLE 345
M.Manoussakis | Axial spondyloarthritis... 340
N. Gatselis | SATELLITE LECTURE 325
M. Mela | SATELLITE LECTURE 273
K. Mimidis | SATELLITE LECTURE 205
Q & A | SATELLITE LECTURE 278
F.Menichetti | Choosing antibiotics in difficult... 508
G. N. Dalekos | SATELLITE SYMPOSIUM 378
N Sipsas | SATELLITE SYMPOSIUM 305
R.Pálsson | European Curriculum of Internal... 351
N.Montano | Choosing wisely: To be or not... 293
P.Mannucci | The role of EFIM publications... 358
G.Lip | Selecting the appropriate antithrombotic... 319
E. Rapti | SATELLITE SYMPOSIUM 1.281
M. Schina | SATELLITE SYMPOSIUM 230
M. Bosilkovski | ORAL PRESENTATIONS OP28-OP33 394
S. Thomson | ORAL PRESENTATIONS OP28-OP33 241
M. Grira | ORAL PRESENTATIONS OP28-OP33 402
J. A. Lopes | Definition, classification... 412
D.Menucci | The role of points of entry... 330
R.Pálsson | Acute kidney injury after abdominal... 353
T.Hofmann | The impact of the International... 284
Q & A | ROUND TABLE 259
D. Vergani | STATE OF THE ART LECTURE 275
H.van Buuren | Scientific and practical... 326
A.Floreani | PBC: Old and novel therapies 276
A.Parés | Variant syndromes: Classification... 329
G.Hirschfield | Deranged cholestatic enzymes... 286
M.Blank | Disease specific IVIG to treat... 341
N. Gatselis | SATELLITE LECTURE 302
M.Ekstedt | Steatosis and metabolic risk... 292
E.Tsochatzis | Non-invasive assessment of... 329
P.Montravers | Reducing the antifungal drugs... 277
Q.Anstee | NAFLD genetics 270
M.Akova | Fighting multi-drug resistant... 330
P.Mannucci | The coagulopathy of chronic... 295
Y.de Boer | Diagnostic evaluation of suspected... 374
A.Alexopoulou | Management and outcome of... 412
C.Marañón | Myeloid populations are altered... 287
G. Papatheodoridis - Current challenges in... 369
S. Manolakokpoulos - New possibilities for... 324
I. Goulis - New combination EBR/GZR: the... 259
I. Vlachogiannakos - Next generation DAAs:... 246
Q & A | SATELLITE SYMPOSIUM 243
A. Floreani | Interview 551
1:10
R. Liberal | Interview 335
1:13
Y. de Boer | Interview 299
0:20